Efficiency of Biomarker-Driven Clinical Trial Designs
- 20 April 2024
- journal article
- letter
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 42 (12) , 1454-1455
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Open-Label, Multicenter, Randomized, Biomarker-Integrated Umbrella Trial for Second-Line Treatment of Advanced Gastric Cancer: K-Umbrella Gastric Cancer StudyJournal of Clinical Oncology, 2024
- What drives cancer clinical trial accrual? An empirical analysis of studies leading to FDA authorisation (2015–2020)BMJ Open, 2022
- Moving Molecular Profiling to Routine Clinical Practice: A Way Forward?JNCI: Journal of the National Cancer Institute, 2019
- Trial Design Challenges and Approaches for Precision Oncology in Rare Tumors: Experiences of the Children’s Oncology GroupJCO Precision Oncology, 2019
- How do you design randomised trials for smaller populations? A frameworkBMC Medicine, 2016
- The questionable use of unequal allocation in confirmatory trialsNeurology, 2014
- Biomarker enrichment strategies: matching trial design to biomarker credentialsNature Reviews Clinical Oncology, 2013
- Randomized Clinical Trials With Biomarkers: Design IssuesJNCI: Journal of the National Cancer Institute, 2010
- Clinical Trial Designs for Predictive Biomarker Validation: Theoretical Considerations and Practical ChallengesJournal of Clinical Oncology, 2009